Search

everythinglearnresearchcommunity

for

Search:↓

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

A medicine company has recalled a drug because it contained an unlisted blood pressure medication.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

A woman with severe angioedema improved significantly after treatment with rituximab.

Different oral anticoagulants cause various non-bleeding side effects, so careful monitoring is needed.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

A woman developed lupus after taking hydroxyurea for two years.

New treatments improved blood pressure control in patients with resistant hypertension.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Pexidartinib often causes liver issues and fatigue, especially in women.

Rivaroxaban may cause hair loss.

Lisinopril, a heart medication, probably caused hair loss in a patient, which stopped after switching drugs.